Improving Gene Therapy Delivery to the Heart and Other Organs
Hydrogel Targeting of Organ Specific Gene Therapy
This project is developing a new way to deliver gene therapy directly to organs like the heart, making treatments more effective.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-11143951 on NIH RePORTER |
What this research studies
Gene therapy holds great promise for treating many diseases, but it's often hard to get the treatment directly to the right organ, especially the heart. This happens because the gene therapy can get lost in the bloodstream or be recognized and stopped by the body's immune system. Our project is developing a new approach using a special gel, called a hydrogel, that can be placed directly on the surface of an organ. This gel is designed to slowly release the gene therapy, helping it reach more cells in the target organ and avoid common delivery problems.
Who could benefit from this research
Good fit: Patients with conditions that could benefit from targeted gene therapy, especially those affecting the heart, may eventually be candidates for treatments developed from this research.
Not a fit: Patients whose conditions are not treatable by gene therapy or do not require highly targeted organ delivery would not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this new delivery method could make gene therapy a more effective treatment for heart disease and other conditions that are currently difficult to treat.
How similar studies have performed: This project explores a novel bioengineering approach to overcome significant challenges that have limited the success of previous gene therapy efforts for heart disease.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Levit, Rebecca Diane — Emory University
- Study coordinator: Levit, Rebecca Diane
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.